# Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV

> **NCT02229760** · PHASE1,PHASE2 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 3 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tipranavir capsules
- **DRUG:** Ritonavir capsules

## Key facts

- **NCT ID:** NCT02229760
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2007-09
- **Final completion:** —
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2014-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229760, "Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02229760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*